OTC Watch

All stocks / ACUT

Accustem Sciences Inc. ACUT

Accustem Sciences (ACUT): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingEstimated float OTCQBNew York, USA
Live quote on OTC Markets

Market listing

Full name
ACCUSTEM SCIENCES INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 13
Source: Stockwatch, 2026-11-17

News headlines

AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
2026-01-08 07:00 ยท News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Net loss
($1,756,096)
What it means

It spends more than it earns

Under strain

The company lost $1.8 million in the year. It reported no sales.

The report says
Cash and cash equivalents
$13,929
Net cash used in operating activities
($850,389)
What it means

The cash could run out soon

Under strain

It had $13,929 in the bank and used about $70,866 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$1,549,446
Total liabilities
$4,951,071
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $1.5 million. Its debts and unpaid bills add up to $5 million. That is about $3.20 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-11-16

Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Estimated float2026-08-14

Estimated float about 16,072,267 shares as of 2026-08-14: 16,072,267 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-03-31

Filed NT 10-K on 2026-03-31: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Shares outstanding

Source: SEC filings
2025-09-30
16.1M
2025-11-12
16.1M
2025-12-31
16.1M
2026-03-31
16.1M
2026-04-14
16.1M
2026-05-15
16.1M
2026-06-30
16.1M
2026-08-14
16.1M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 NT 10-QNT 10-Q
2026-08-14 10-Q10-Q
2026-05-15 10-Q10-Q
2026-04-14 10-K10-K
2026-03-31 NT 10-KNT 10-K
2025-11-26 8-K8-K

Common questions about ACUT

Does ACUT file reports with the SEC?

Yes. Accustem Sciences files with the SEC under company number 0001850767. The most recent filing we hold is a NT 10-Q dated 2026-11-16.

Source record

How many ACUT shares are outstanding?

16,072,267 shares as of 2026-08-14, as reported to the SEC.

Source record

Has ACUT filed reports late?

Yes. In the last 12 months it filed 2 late-filing notices, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Accustem Sciences making money?

The company lost $1.8 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record